Table 2.
Metabolic Syndrome and Its Components |
Hungarian General Population (n = 397) | Hungarian Roma Population (n = 368) | p-Value | Males in the HG Population (n = 177) | Males in the HR Population (n = 97) | p-Value | Females in the HG Population (n = 220) | Females in the HR Population (n = 271) | p-Value |
---|---|---|---|---|---|---|---|---|---|
Prevalence % (95% CI) |
Prevalence % (95% CI) |
Prevalence % (95% CI) |
Prevalence % (95% CI) |
Prevalence % (95% CI) |
Prevalence % (95% CI) |
||||
Central obesity | 75.56 (70.11–78.65) |
73.37 (68.68–77.69) |
0.719 | 64.41 (57.17–71.18) |
58.76 (48.83–68.18) |
0.356 | 82.73 (77.32–87.28) |
78.60 (73.43–83.16) |
0.251 |
Raised blood pressure or treated hypertension | 57.18 (52.27–61.98) |
54.08 (48.97–59.12) |
0.378 | 60.45 (53.13–67.44) |
57.73 (47.79–67.22) |
0.661 | 54.55 (47.94–61.03) |
52.77 (46.82–58.66) |
0.694 |
Raised fasting plasma glucose concentration or previously diagnosed diabetes mellitus | 25.19 (21.11–29.63) |
23.91 (19.77–28.46) |
0.666 | 27.12 (20.98–34.00) |
31.96 (23.31–41.66) |
0.398 | 23.64 (18.39–29.57) |
21.03 (16.50–26.18) |
0.490 |
Raised triglyceride level or treated lipid disorder | 37.28 (32.63–42.11) |
37.77 (32.93–42.81) |
0.767 | 42.94 (35.81–50.30) |
51.55 (41.68–61.32) |
0.172 | 32.73 (26.78–39.12) |
32.84 (27.46–38.59) |
0.979 |
Reduced HDL cholesterol level or treated lipid disorder | 36.27 (31.66–41.09) |
55.98 (50.88–60.99) |
<0.001 | 32.20 (25.65–39.33) |
47.42 (37.68–57.31) |
0.013 | 39.55 (33.26–46.11) |
59.04 (53.12–64.77) |
<0.001 |
Metabolic syndrome | 39.80 (35.07–44.67) |
44.02 (39.01–49.12) |
0.232 | 37.85 (30.95–45.15) |
46.39 (36.70–56.30) |
0.169 | 41.36 (35.00–47.95) |
43.17 (37.37–49.12) |
0.687 |
Significant differences are highlighted in grey. 95% CI: 95% confidence interval.